Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients
- Nikolaou, Vasiliki A
- Apalla, Zoe
- Carrera, Cristina
- Fattore, Davide
- Sollena, Pietro
- Riganti, Julia
- Segura, Sonia
- Freites-Martinez, Azael
- Lallas, Konstantinos
- Romano, Maria Concetta
- Oikonomou, Chrysa
- Starace, Michela
- Dimopoulos, Meletios A
- Kyrgidis, Athanassios
- Lazaridou, Elizabeth
- Giavedoni, Priscila
- Annunziata, Maria Carmela
- Peris, Ketty
- Echeverría, Maria
- Lopez-Tujillo, Emilio
- Syrigos, Konstandinos
- Papageorgiou, Chryssoula
- Podlipnik, Sebastian
- Fabbrocini, Gabriella
- Torre, Ana C
- Kemanetzi, Christina
- Villa-Crespo, Lorena
- Lallas, Aimilios
- Stratigos, Alexander J
- Sibaud, Vincent
DOIAbstract
Cutaneous immune-related adverse events (irAEs) represent the most frequent toxicities induced by immune checkpoint inhibitors (ICIs)
Add to ORKG